Patents by Inventor Neil R. Anderson

Neil R. Anderson has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • ?-carboline pharmaceutical compositions
    Patent number: 7182958
    Abstract: Formulations containing a PDE5 inhibitor, a water-soluble diluent, a lubricant, a hydrophilic binder, a disintegrant, and optional microcrystalline cellulose and/or a wetting agent, and their use in treating sexual dysfunction, are disclosed.
    Type: Grant
    Filed: April 26, 2000
    Date of Patent: February 27, 2007
    Assignee: Lilly Icos LLC.
    Inventors: Peter L. Oren, Neil R. Anderson, Martha A. Kral
  • ?-carboline pharmaceutical compositions
    Patent number: 6841167
    Abstract: A soft capsule containing a solution or suspension of a PDE5 inhibitor, and use of the capsule in treating sexual dysfunction.
    Type: Grant
    Filed: April 26, 2000
    Date of Patent: January 11, 2005
    Assignee: Lilly Icos LLC.
    Inventors: Neil R. Anderson, Rampurna P. Gullapalli
  • Beta-carboline drug products
    Patent number: 6821975
    Abstract: A compound of structural formula (I), and pharmaceutically acceptable salts and solvates thereof, wherein the compound is in free drug particulate form, is disclosed.
    Type: Grant
    Filed: July 19, 2002
    Date of Patent: November 23, 2004
    Assignee: Lilly ICOS LLC
    Inventors: Neil R. Anderson, Kerry J. Hartauer, Martha A. Kral, Gregory A. Stephenson
  • Method for the treatment of CNS disorders
    Patent number: 5985322
    Abstract: An improved method for the treatment of central nervous system disorders comprises treating patients with an enteric fluoxetine formulation.
    Type: Grant
    Filed: March 10, 1999
    Date of Patent: November 16, 1999
    Assignee: Eli Lilly and Company
    Inventors: Neil R. Anderson, Roger F. Harrison, Daniel F. Lynch, Peter L. Oren
  • Fluoxetine enteric pellets and methods for their preparation and use
    Patent number: 5910319
    Abstract: A superior enteric formulation of the antidepressant drug, fluoxetine, is in the form of enteric pellets of which the enteric layer comprises hydroxypropylmethylcellulose acetate succinate.
    Type: Grant
    Filed: May 29, 1997
    Date of Patent: June 8, 1999
    Assignee: Eli Lilly and Company
    Inventors: Neil R. Anderson, Roger G. Harrison, Daniel F. Lynch, Peter L. Oren
  • Duloxetine enteric pellets
    Patent number: 5508276
    Abstract: A superior enteric formulation of the antidepressant drug, duloxetine, is in the form of enteric pellets of which the enteric layer comprises hydroxypropylmethylcellulose acetate succinate.
    Type: Grant
    Filed: July 18, 1994
    Date of Patent: April 16, 1996
    Assignees: Eli Lilly and Company, Shionogi & Co.
    Inventors: Neil R. Anderson, Peter L. Oren, Toshihiro Ogura, Toshiro Fujii